Comprehensive Study Notes: Hematology, Blood Composition, and Transfusion Medicine

Hematological Foundations and the Cellular Level of Organization

  • The study of human biology follows a hierarchical structure that starts at the cellular level and progresses through complex layers.
  • The hierarchy of organization is as follows:
    • Cells
    • Tissues
    • Organs
    • Organ Systems
    • The Entire Organism (Human)
  • Blood cells represent the foundational cellular components discussed in the context of Chapter 1 concepts.

Platelet Disorders: Thrombocytopenia and Thrombocytosis

  • Thrombocytes: These are the blood cells responsible for clotting (platelets).
  • Thrombocytopenia:
    • Definition: A condition characterized by an abnormally low platelet count.
    • Physiological Implication: The body is unable to form clots effectively.
    • Patient Experience: The speaker describes the sensation as needing "to bleed and bleed and bleed" because the clotting mechanism is absent. Minor contact can result in immediate bruising.
  • Thrombocytosis:
    • Definition: A condition where there are too many thrombocytes/platelets.
    • Physiological Implication: The patient is at a high risk for clotting (thrombus formation).
    • Nursing Intervention: Healthcare providers must watch these patients "like a hawk" because they can "throw a clot real quick."
  • Reference Range: A normal platelet count is generally cited up to 400,000 cells/μL400,000\,cells/\mu L.

The Five Components of a Complete Blood Count (CBC)

  • A routine CBC test measure five core components:
    1. Leukocytes: White blood cells (WBCs).
    2. Erythrocytes: Red blood cells (RBCs).
    3. Hemoglobin (abbreviated as HGBHGB or HDBHDB in transcript nodes).
    4. Hematocrit (abbreviated as HCTHCT or "crit").
    5. Thrombocytes: Platelets.
  • CBC with Differential (Diff): This is a more detailed version of the CBC that breaks down leukocytes into specific types to identify particular infections.
  • The differential differentiates among:
    • Monocytes
    • Eosinophils
    • Basophils
    • Lymphocytes
    • Neutrophils

Hemoglobin and Hematocrit (The H&H)

  • Hemoglobin (HGBHGB):
    • Responsibility: Oxygenation. It is the actual molecule within the erythrocyte that carries oxygen (O2O_2).
    • Metaphor: It is described as a "balloon within a balloon" (the hemoglobin molecule inside the red blood cell).
    • Normal values: Ideally in the double digits (around 15 g/dL15\,g/dL for healthy adults). Values in the single digits (e.g., 5 g/dL5\,g/dL or 8 g/dL8\,g/dL) are critically low and may require intervention.
  • Hematocrit (HCTHCT):
    • Definition: The percentage of blood volume that is composed of red blood cells.
    • The "Rule of Three": The hematocrit is calculated as the hemoglobin value multiplied by three.
    • Formula: HCT=HGB×3HCT = HGB \times 3
    • Example: If a patient's HGBHGB is 15 g/dL15\,g/dL, their HCTHCT should be approximately 45%45\%.
    • Target: Clinicians generally look for a hematocrit of approximately 50%50\%.

Acute vs. Chronic Blood Loss

  • The body's response to anemia depends significantly on the speed of onset.
  • Acute Blood Loss:
    • Definition: Rapid loss of blood (e.g., hemorrhage in the ER).
    • Symptoms: Severe and immediate. A patient with an acute drop to an HGBHGB of 8 g/dL8\,g/dL might look like a "fish out of water" (gasping, symptomatic).
    • Transfusion threshold: Often starts at an HGBHGB of 8 g/dL8\,g/dL for acute loss.
  • Chronic Blood Loss/Anemia:
    • Definition: Blood levels drop slowly over a long period (e.g., years).
    • Physiological Adaptation: The body has time to acclimate and adjust to lower oxygen-carrying capacities.
    • Example: A patient who chronically lives with an HGBHGB of 8 g/dL8\,g/dL might be able to function on a treadmill without apparent distress because their "baseline" has shifted.

Renal Function and Erythropoiesis

  • The renal system (kidneys) has critical functions beyond waste filtration and the low-flow filtration of blood.
  • Erythropoietin (EPO):
    • It is a hormone secreted by the kidneys.
    • Pathway: The kidneys secrete EPO, which travels to the bone marrow.
    • Function: EPO tells the bone marrow to produce more red blood cells.
  • Clinical Connection: Chronic Kidney Disease (CKD):
    • Patients in renal failure are almost always anemic because their kidneys no longer produce EPO.
    • This knowledge allows a nurse to predict anemia based on A&P knowledge without even looking at lab values.
  • Pharmacological Interventions:
    • Epogen: A synthetic version of erythropoietin used to treat anemia in renal failure. Estimated cost is approximately $289\$289 per dose.
    • Neupogen: A synthetic medication used to help the body produce white blood cells (leukocytes).
    • Dialysis patients may receive injections of these medications in their dialysate (estimated dialysis bottle cost: $500\$500).

Erythrocyte Life Cycle and Recycling

  • Lifespan: Red blood cells live for approximately 120 days120\,\text{days}.
  • Recycling Process: When an erythrocyte dies, it is not simply discarded; its components are recycled.
  • Key Resource: Figure 15.6 on page 297 of the textbook details the breakdown of old RBCs.
  • Stem Cells: Located in the bone marrow, these are undifferentiated cells that can become "anything I need them to be," including RBCs, WBCs, and platelets.

Blood Typing and Transfusion Science

  • Antigens and Antibodies:
    • Blood types are determined by antigens on the surface of the cell.
    • Type A: Has A antigens.
    • Type B: Has B antigens.
    • Type AB: Has both A and B antigens.
    • Type O: Has zero (none) antigens.
  • Agglutination: If a patient is given incompatible blood, the blood cells act like glue and clump together (agglutinate), causing a dangerous reaction.
  • Transfusion Rules:
    • You cannot give a patient an antigen they do not already have (e.g., you cannot give Type B blood to a Type A person).
    • You can give a patient "nothing" (Type O blood contains no antigens, so it does not trigger a reaction in A, B, or AB recipients).
  • Universal Classifications:
    • Universal Donor: O-negative (O−O^-). It has no antigens and no Rhesus factor.
    • Universal Recipient: AB-positive (AB+AB^+). They already possess all major antigens.
  • The Rhesus (Rh) Factor:
    • Denoted as positive (+$) or negative (-).\n - A negative patient cannot receive positive blood because they do not have the Rh antigen.\n\n# Nursing Standards of Care in Transfusion\n\n- Administering blood is a "life or death situation" and failure to follow protocol is considered a **sentinel event**.\n- **Transfusion Phases**:\n - **Pre-transfusion**: Checking vitals, confirming patient ID with a second licensed professional, and checking the blood bag against the order.\n - **Intra-transfusion**: Monitoring the patient during the infusion for reactions.\n - **Post-transfusion**: Documenting and monitoring recovery.\n- **Critical Timelines and Protocols**:\n - Nurses must know how long blood can stay out of the blood bank before infusion.\n - Nurses must know the maximum duration for an infusion and requirements for tubing changes.\n- **The "Why" of Nursing**: Success is not just being able to start an IV; it is understanding the evidence-based practice and the physiological "why" behind the procedure.\n\n# Specialized Blood Scenarios\n\n- **Emergency Transfusion**: In a critical trauma (e.g., a car accident with liver laceration), there is no time to cross-match blood. Surgeons will use **O-negative** blood immediately to prevent death.\n- **Autologous Blood Donation**: A patient planning a surgery a month in advance can "bank" their own blood to be used if they bleed during the procedure.\n- **Cell Saver (Auto-transfusion)**: A machine that collects blood lost by the patient during surgery or from a chest tube, filters it, and gives it back to the same patient.\n- **O3 Therapy**: A historical or alternative mention of treating blood with ozone (O_{3}$$) before re-infusion.

Questions & Discussion

  • Question: Is the blood being transfused artificial?
  • Answer: No. While science has created an artificial heart, we do not yet have the technology to create artificial blood.
  • Question: Can you give a negative person positive blood?
  • Answer: No. You would be giving them an antigen they do not have, which causes a reaction.
  • Question: What is a baseline?
  • Answer: A baseline is an individual's "normal." For example, someone in an abusive situation or living in poverty may consider that "normal" for them, even if it is objectively abnormal. In medicine, a patient's chronic anemia may be their personal baseline, necessitating different care than someone with acute loss.